Hepion Pharmaceuticals, Inc. (CTRVP) Shareholders’ equity 2020–2023
Hepion Pharmaceuticals, Inc. (CTRVP) shareholders’ equity at each fiscal year-end, per SEC filings.
$7.3MFY2023 · since FY2020: $40.5M → $7.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $7.3M | -85.4% |
| FY2022 | $49.9M | -46.4% |
| FY2021 | $93.0M | +129.5% |
| FY2020 | $40.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice